Aspira Pathlab & Diagnostics has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, February 13, 2021 to Consider and approve the unaudited financial results of the Company for the quarter ended December 31, 2020. Further, the company has informed that in terms of the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in securities of the Company has been closed with effect from January 01, 2021 and shall re-open 48 hours after the financial results are made public.
The above information is a part of company’s filings submitted to BSE.